Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Rigel Pharmaceuticals
Biotech
Idorsia locks in new CEO after shakeup—Chutes & Ladders
Idorsia locks in new CEO after shakeup. NovaBridge nabs short-lived Idorsia chief as new CEO. Muna scoops former iTeos CEO as new leader.
Darren Incorvaia
,
Zoey Becker
,
Will Maddox
,
Marissa Russo
Jul 10, 2026 8:30am
Lilly reneges on remainder of Rigel RIPK1 deal
Apr 22, 2026 3:00pm
Lilly pulls out of CNS portion of $960M collab with Rigel
Nov 5, 2025 7:00am
Another Biogen exec hitches ride to Voyager —Chutes & Ladders
Mar 15, 2024 9:30am
Rigel bets $230M on Forma's leukemia drug
Aug 2, 2022 4:01pm
Eli Lilly hands over $125M to Rigel for experimental drug deal
Feb 18, 2021 8:05am